The Future of Obesity and Overweight

40% of adults in the US suffer from obesity. We're excited by the data we've produced with our drug, which is called terzipatide. It's a dual acting in Curtin agonist. These drugs were developed originally this category for diabetes. The first one actually almost 20 years ago using one hormone that your stomach secretes when you eat.